Please assess the completion status of the following clinical trial:

Trial Title: SkinPen Efficacy on Acne Scars on the Face and/or Back

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men and women 18 to 60 years of age.~* Subjects in good health.~* Approximately 5 to 10 atrophic acne scars of mixed types (boxcar and/or rolling scars with some icepick scars allowed) on face and/or back that are moderate to severe.~* Desire correction of his/her acne scarring.~* Subjects of child bearing potential must take a urine pregnancy test and must test negative.~* Subjects willing to sign a photography release.~* Willingness to cooperate and participate by following study requirements.~Exclusion Criteria:~* Allergies to facial or general skin care products~* Presence of an active systemic or local skin disease.~* Severe solar elastosis.~* Sensitivity to topical lidocaine.~* Recent history of significant trauma to the face (\< 6 months).~* Significant scarring other than acne scars in treated area(s).~* Severe of cystic active and clinically significant acne on the area(s) to be treated.~* History of systemic granulomatous diseases.~* History of hypertrophic or keloid scars.~* Current cancerous or pre-cancerous lesions in area(s) to be treated.~* Had microdermabrasion or glycolic acid treatment to treatment area(s) within 1 month prior to study participation.~* History of chronic drug or alcohol abuse.~* Current smokers or have smoked in the last 5 years.~* History of cosmetic treatments: Skin tightening within last year, injectable filler of any type within the last year, neurotoxins within the last 3 months, ablative resurfacing laser treatments, non-ablative, rejuvanative laser treatments in last 6 months, chemical peel, dermabrasion, non-ablative laser or fractional laser resurfacing of face and neck within the last 4 weeks.~* History of certain prescription medications (accutane or other retinoids, topical retinoids, prescription strength skin lightening devices, anti-wrinkle, skin lightening devices, antiplatelet agents/Anticoagulants, and/or psychiatric drugs).~* Nursing, pregnant, or planning to become pregnant during study.~* Current or pre-existing dermatologic diseases on the face or body (psoriasis, rosacea, eczema, etc.)~* History of immunosupression/immune deficiency disorders.~* Current or history of uncontrolled disease such as asthma, diabetes, hyperthyroidism, etc.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- SkinPen II (Type: ACTIVE_COMPARATOR): Three treatments using SkinPen II aesthetic microneedling device to each patient, with each treatment spaced one month apart.
- SkinPen Precision (Type: ACTIVE_COMPARATOR): Three treatments using SkinPen Precision aesthetic microneedling device to each patient, with each treatment spaced one month apart.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete